1. Home
  2. SG vs BWAY Comparison

SG vs BWAY Comparison

Compare SG & BWAY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Sweetgreen Inc.

SG

Sweetgreen Inc.

HOLD

Current Price

$5.85

Market Cap

641.7M

ML Signal

HOLD

Logo BrainsWay Ltd.

BWAY

BrainsWay Ltd.

HOLD

Current Price

$14.72

Market Cap

578.5M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SG
BWAY
Founded
2007
2003
Country
United States
Israel
Employees
N/A
N/A
Industry
Restaurants
Medical/Dental Instruments
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
641.7M
578.5M
IPO Year
2021
2011

Fundamental Metrics

Financial Performance
Metric
SG
BWAY
Price
$5.85
$14.72
Analyst Decision
Hold
Strong Buy
Analyst Count
15
2
Target Price
$8.43
$13.25
AVG Volume (30 Days)
6.5M
166.7K
Earning Date
05-07-2026
05-13-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
0.82
N/A
Revenue
$679,474,000.00
N/A
Revenue This Year
$7.60
$309.69
Revenue Next Year
$8.45
$26.21
P/E Ratio
$7.17
$81.98
Revenue Growth
0.39
N/A
52 Week Low
$4.49
$11.77
52 Week High
$10.63
$26.63

Technical Indicators

Market Signals
Indicator
SG
BWAY
Relative Strength Index (RSI) 42.26 44.01
Support Level $5.07 $14.13
Resistance Level $6.12 $14.85
Average True Range (ATR) 0.42 0.88
MACD 0.08 -0.05
Stochastic Oscillator 43.09 6.94

Price Performance

Historical Comparison
SG
BWAY

About SG Sweetgreen Inc.

Sweetgreen Inc is a mission-driven, next-generation restaurant and lifestyle brand that serves healthy food at scale. Its bold vision is to be as ubiquitous as traditional fast food, but with the transparency and quality that consumers increasingly expect. It is creating plant-forward, seasonal, and earth-friendly meals from fresh ingredients and produce that prioritizes organic, regenerative, and local sourcing. Its menu involves, Kids' meal, salads, sides, local items, Protein Plates, Desserts, Drinks and Others.

About BWAY BrainsWay Ltd.

BrainsWay Ltd is engaged in advanced noninvasive neurostimulation treatments for mental health disorders. The company is advancing neuroscience with its proprietary Deep Transcranial Magnetic Stimulation (Deep TMS) platform technology to improve health and transform lives. Current indications include depressive disorder (including reduction of anxiety symptoms, commonly referred to as anxious depression), obsessive-compulsive disorder, and smoking addiction. Additional clinical trials of Deep TMS in various psychiatric, neurological, and addiction disorders are underway. The company derives revenues from the lease and sale of Deep TMS systems.

Share on Social Networks: